EUVIMEDEUVIMED entdecken
ZwillingsstudieOpen Access · CC BY-NC-ND 4.0

Long‐Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease

Kensuke Daida iD, Manabu Funayama iD, Kimberley J Billingsley iD, Laksh Malik, Abigail Miano-Burkhardt, Hampton L Leonard, Mary B Makarious iD, Hirotaka Iwaki iD, Jinhui Ding, J Raphael Gibbs, Mayu Ishiguro, Hiroyo Yoshino und 7 weitere

Movement Disorders · 2023

DOI: 10.1002/mds.29610 ↗

Kurz gefasst

Zwillingsstudie in der Zeitschrift Movement Disorders, 2023. Verfasst von Kensuke Daida und 18 weiteren Autor:innen. Beteiligte Einrichtung: Integrative Neurogenomics Unit, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Parkinsonian Disorders. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, Intramural NIH HHS, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkin RBR E3 ubiquitin‐protein ligase ( PRKN ) mutations are the most common cause of young onset and autosomal recessive Parkinson's disease (PD). PRKN is located in FRA6E, which is one of the common fragile sites in the human genome, making this region prone to structural variants. However, complex structural variants such as inversions of PRKN are seldom reported, suggesting that there are potentially unrevealed complex pathogenic PRKN structural variants.

Objectives

To identify complex structural variants in PRKN using long‐read sequencing.

Methods

We investigated the genetic cause of monozygotic twins presenting with a young onset dystonia‐parkinsonism using targeted sequencing, whole exome sequencing, multiple ligation probe amplification, and long‐read sequencing. We assessed the presence and frequency of complex inversions overlapping PRKN using whole‐genome sequencing data of Accelerating Medicines Partnership Parkinson's disease (AMP‐PD) and United Kingdom (UK)‐Biobank datasets.

Results

Multiple ligation probe amplification identified a heterozygous exon three deletion in PRKN and long‐read sequencing identified a large novel inversion spanning over 7 Mb, including a large part of the coding DNA sequence of PRKN . We could diagnose the affected subjects as compound heterozygous carriers of PRKN . We analyzed whole genome sequencing data of 43,538 participants of the UK‐Biobank and 4941 participants of the AMP‐PD datasets. Nine inversions in the UK‐Biobank and two in AMP PD were identified and were considered potentially damaging and likely to affect PRKN expression.

Conclusions

This is the first report describing a large 7 Mb inversion involving breakpoints outside of PRKN . This study highlights the importance of using long‐read sequencing for structural variant analysis in unresolved young‐onset PD cases. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseParkinsonian DisordersHumansHeterozygoteMutationUbiquitin-Protein Ligases

Stichwörter der Autor:innen

PARK2Parkinson's diseaseinversionlong-read sequencingstructural variant

Substanzen

Ubiquitin-Protein Ligasesparkin protein

Autor:innen und Institutionen

  • Integrative Neurogenomics Unit, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
  • Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Data Tecnica International LLC, Washington, DC, USA.

ORCID-Profile: Kensuke Daida, Manabu Funayama, Kimberley J Billingsley, Mary B Makarious, Hirotaka Iwaki, Genko Oyama, Cornelis Blauwendraat

Förderung

  • NINDS NIH HHS
  • Intramural NIH HHS
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Daida, K., Funayama, M., Billingsley, K. J., Malik, L., Miano-Burkhardt, A., Leonard, H. L., Makarious, M. B., Iwaki, H., Ding, J., Gibbs, J. R., Ishiguro, M., Yoshino, H., Ogaki, K., Oyama, G., Nishioka, K., Nonaka, R., Akamatsu, W., Blauwendraat, C., & Hattori, N. (2023). Long‐Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.29610

Vancouver

Daida K, Funayama M, Billingsley KJ, Malik L, Miano-Burkhardt A, Leonard HL, et al. Long‐Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease. Movement Disorders. 2023. doi:10.1002/mds.29610

BibTeX
@article{Daida2023,
  author = {Daida, Kensuke and Funayama, Manabu and Billingsley, Kimberley J and Malik, Laksh and Miano-Burkhardt, Abigail and Leonard, Hampton L and Makarious, Mary B and Iwaki, Hirotaka and Ding, Jinhui and Gibbs, J Raphael and Ishiguro, Mayu and Yoshino, Hiroyo and Ogaki, Kotaro and Oyama, Genko and Nishioka, Kenya and Nonaka, Risa and Akamatsu, Wado and Blauwendraat, Cornelis and Hattori, Nobutaka},
  title = {Long‐Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease},
  journal = {Movement Disorders},
  year = {2023},
  doi = {10.1002/mds.29610}
}
Kostenlos starten →